Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Nordea suspends two analysts over COVID research note equating lockdowns with prison

Published 26/11/2021, 16:09
Updated 26/11/2021, 16:10
© Reuters.

By Essi Lehto

HELSINKI (Reuters) - Finland's Nordea bank has suspended two senior analysts from publishing research, the bank said on Friday, and is investigating how a research note equating lockdowns with prison "or worse" made its way onto Nordea's website.

The 1,900-word note entitled "Papers please, and how to trade them!" said an uncertain market situation had been created by "lockdownistas" imposing vaccine mandates and restrictions.

"It used to be "two weeks to flatten the curve", but somehow it has developed to "imprison the unvaccinated (or worse)", the note said, going on to imply governments had not learned lessons on human freedom from the trials of Nazis after World War Two.

"Leaving aside the lessons from the Nuremberg trials such as bodily integrity, informed choice, the impact on civil liberties, and so on (because who cares?), lockdown policies, vaccine mandates and so on do carry costs," the note said.

Nordea deleted the note on Wednesday and said it would look into "how the analysis was conducted and the process behind its publication".

"We have initiated an internal review, and the two analysts will not write or publish during the review," Nordea's Chief communicator Tuomas Forsell told Reuters in repose to questions about the analysts named on the note, Martin Enlund and Andreas Steno Larsen.

Neither analyst was immediately available for comment.

Forsell said the publication process varies at the bank but would not comment on how and why the note criticising COVID-19 vaccine rollouts and restrictions was published on Sunday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The note also made the unsubstantiated suggestion that booster shots made people more vulnerable to infection immediately afterwards and thus drove up infection rates. "Booster shots will likely give case growth… …a boost," it said.

The bank said it would leave medical advice to medical experts.

"It is clear that we have failed in this case, and we apologise for that," Head of large corporates and institutions Martin Persson said in a statement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.